Response of plasmacytomas to low-dose thalidomide in a patient with refractory multiple myeloma

Authors

  • Christian Ribas From the Departments of Hematology e Hemotherapy (C. Ribas, G.W.B. Colleoni, M.S.S. Almeida, C.R. Duch), Radiotherapy (C.B. Ohashi, R.A. Segreto) and Pathology (M.R.R. Silva), UNIFESP/EPM, Sa ̃o Paulo, Brazil
  • Gisele Colleoni From the Departments of Hematology e Hemotherapy (C. Ribas, G.W.B. Colleoni, M.S.S. Almeida, C.R. Duch), Radiotherapy (C.B. Ohashi, R.A. Segreto) and Pathology (M.R.R. Silva), UNIFESP/EPM, Sa ̃o Paulo, Brazil
  • Manuella Almeida From the Departments of Hematology e Hemotherapy (C. Ribas, G.W.B. Colleoni, M.S.S. Almeida, C.R. Duch), Radiotherapy (C.B. Ohashi, R.A. Segreto) and Pathology (M.R.R. Silva), UNIFESP/EPM, Sa ̃o Paulo, Brazil
  • Cibele Repele Duch From the Departments of Hematology e Hemotherapy (C. Ribas, G.W.B. Colleoni, M.S.S. Almeida, C.R. Duch), Radiotherapy (C.B. Ohashi, R.A. Segreto) and Pathology (M.R.R. Silva), UNIFESP/EPM, Sa ̃o Paulo, Brazil
  • Cláudio Ohashi From the Departments of Hematology e Hemotherapy (C. Ribas, G.W.B. Colleoni, M.S.S. Almeida, C.R. Duch), Radiotherapy (C.B. Ohashi, R.A. Segreto) and Pathology (M.R.R. Silva), UNIFESP/EPM, Sa ̃o Paulo, Brazil
  • Roberto Segreto From the Departments of Hematology e Hemotherapy (C. Ribas, G.W.B. Colleoni, M.S.S. Almeida, C.R. Duch), Radiotherapy (C.B. Ohashi, R.A. Segreto) and Pathology (M.R.R. Silva), UNIFESP/EPM, Sa ̃o Paulo, Brazil
  • Maria Regina Silva From the Departments of Hematology e Hemotherapy (C. Ribas, G.W.B. Colleoni, M.S.S. Almeida, C.R. Duch), Radiotherapy (C.B. Ohashi, R.A. Segreto) and Pathology (M.R.R. Silva), UNIFESP/EPM, Sa ̃o Paulo, Brazil

DOI:

https://doi.org/10.1080/02841860310021536

Abstract

No Abstract Available

Downloads

Download data is not yet available.

Downloads

Published

2004-03-01

How to Cite

Ribas, C., Colleoni, G. ., Almeida, M., Repele Duch, C., Ohashi, C., Segreto, R., & Regina Silva, M. (2004). Response of plasmacytomas to low-dose thalidomide in a patient with refractory multiple myeloma. Acta Oncologica, 43(2), 215–216. https://doi.org/10.1080/02841860310021536